Azepine derivatives as gammasecretase inhibitors

Details for Australian Patent Application No. 2008287124 (hide)

Owner Eli Lilly and Company

Inventors Reel, Jon Kevin; Rubio-Esteban, Almudena; Miller, Melinda Joy Hope; Porter, Warren Jaye

Agent Spruson & Ferguson

Pub. Number AU-A-2008287124

PCT Pub. Number WO2009/023453

Priority 60/955,720 14.08.07 US

Filing date 4 August 2008

Wipo publication date 19 February 2009

International Classifications

C07D 223/12 (2006.01) Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

Event Publications

28 January 2010 PCT application entered the National Phase

  PCT publication WO2009/023453 Priority application(s): WO2009/023453

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008287128-Immunoglobulin cleavage fragments as disease indicators and compositions for detecting and binding such

2008287115-Device and method for assisting in flexor tendon repair and rehabilitation